Biography:
Younok Dumortier Shin, PhD, MBA. has more than 20 years of experience in pharmaceutical and biotech industry including GlaxoSmithKline, Bristol Meyers Squibb, Johnson and Johnson, Allergan, Dermelix and Avalo Therapeutics. During her career, she oversaw many multibillion-product launches around the world, owned responsibilities for uninterrupted commercial supply, and championed creating innovative drug development programs to accelerate the clinical and regulatory approval timelines. Currently, she is serving as the CEO of OnusBio, a biotechnology company focusing on developing innovative medicines to treat debilitating conditions affecting nervous systems.
Title : Redefining holistic approaches in neurological drug development: Gaps and opportunities
Title : Challenges in translating science into medicine in the field of brain health